Cayman Chemical, 78755-81-4, Biologically Active Small Molecules

Sort
View
Show
  • Cayman Chemical

    An imidazobenzodiazepine derivative that competitively inhibits benzodiazepine binding to GABAA receptors (IC50 = 2 nM); used to reverse sedation induced by benzodiazepine drugs and is effective in the treatment of benzodiazepine overdose or withdrawal.